Clinical Trial Opportunity for Triple-Negative Breast Cancer
| Date | Form | Description | XBRL | Pages |
|---|---|---|---|---|
| 06/28/19 | SC 13G | Form SC 13G: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions | 9 | |
| 06/14/19 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 2 | |
| 06/14/19 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 2 | |
| 06/14/19 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 2 | |
| 06/14/19 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 2 | |
| 06/14/19 | 4 | Form 4: Statement of changes in beneficial ownership of securities | 2 | |
| 06/14/19 | 8-K | Form 8-K: Current report filing | 16 | |
| 06/11/19 | CORRESP | Form CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission. | 1 | |
| 06/11/19 | EFFECT | Form EFFECT: Notice of Effectiveness | 1 | |
| 06/07/19 | UPLOAD | Form UPLOAD: SEC-generated letter | 1 |